Copyright
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 114818
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.114818
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.114818
Rectal neuroendocrine tumors: Update
Mohammed Khayyat, King Abdulaziz University College of Medicine, King Abdulaziz University Hospital, Jeddah 214455, Saudi Arabia
Yasir M Khayyat, Department of Medicine, Faculty of Medicine, Umm AL-Qura University, Makkah 8156-24381, Saudi Arabia
Author contributions: Khayyat M performed literature review, collection and Khayyat YM performed initial drafting and final review of the manuscript.
Conflict-of-interest statement: Both authors have nothing to disclose.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yasir M Khayyat, Professor, Department of Medicine, Faculty of Medicine, Umm AL-Qura University, AlAwali District, Makkah 8156-24381, Saudi Arabia. ymkhayyat@uqu.edu.sa
Received: September 29, 2025
Revised: October 11, 2025
Accepted: November 18, 2025
Published online: January 15, 2026
Processing time: 105 Days and 18.5 Hours
Revised: October 11, 2025
Accepted: November 18, 2025
Published online: January 15, 2026
Processing time: 105 Days and 18.5 Hours
Core Tip
Core Tip: This manuscript highlights that, although rare, rectal neuroendocrine tumors exhibit distinct prognostic and therapeutic profiles. Key innovations include the identification of metabolic syndrome components as risk factors, the prognostic value of vascular patterns and biomarkers such as chromogranin A as well as the refined endo
